Our focus is simple: stop Alzheimer’s before it starts. This disease steals the moments that make us who we are and the memories we share. That’s why we believe in attacking Alzheimer’s from every angle — because every breakthrough means more time, more hope and more moments together for families who can’t wait.
Brendan Whitelaw, MD, PhD, is a third year in the Adult Neurology Residency Program at Washington University School of Medicine in St. Louis. He is planning to specialize in vascular neurology and pursue a career as a physician scientist studying the molecular mechanisms driving cerebrovascular disease. Whitelaw went to college at the University of Pennsylvania, […]
Sarah Biber, PhD, is an interdisciplinary researcher whose work integrates data science, bioinformatics, human-centered systems engineering, and implementation science. From 2021 to 2025, she co-led the National Alzheimer’s Coordinating Center (NACC) as Executive Director and multi-Principal Investigator (mPI), guiding its transformation into a modern multimodal cloud-based platform that integrates longitudinal clinical, imaging, neuropathological, biomarker, genomic […]
Alzheimer’s disease is notorious for scrambling patients’ daily rhythms. Restless nights with little sleep and increased napping during the day are early indicators of disease onset, while sundowning, or confusion later in the day, is typical for later stages of the disease. These symptoms suggest a link between the progression of the disease and the […]
Jan Kubanek, PhD, joined the faculty of WashU Medicine Department of Psychiatry on August 1, 2025, as associate professor of psychiatry in the Division of Clinical Neuroscience and Behavioral Health, with secondary appointments in the Department of Neurology and Department of Radiology. He brings combined experience in human and macaque electrophysiology, human and macaque behavioral […]
Scientists may have reached a breakthrough in the fight against Huntington’s disease, a rare and fatal inherited brain disorder with no cure. For the first time, a gene therapy has been shown in clinical trials to significantly slow the progression of the disease, raising cautious optimism among researchers and families.
Congratulations to the members of the Department of Neurology who received accolades through the Supporting a Fair Environment (SAFE) program! SAFE aims to improve the learning environment by promoting positive behaviors and managing concerns about learner mistreatment and unprofessional behaviors. SAFE accolades include treating others with dignity and respect, creating an environment that values diversity, […]
Impeding a link between the body’s natural clock and the brain may help reduce neurodegeneration in mice modeling Alzheimer’s disease, according to a new study led by researchers at WashU Medicine and published in Nature Aging.
Conrad Weihl, MD, PhD, was installed as the Gabe Weil Professor on Tuesday, Sept. 23, 2025. The ceremony included remarks from David Perlmutter, MD, executive vice chancellor for medical affairs and the George and Carol Bauer Dean of Washington University School of Medicine in St. Louis, Chuck Rickert, MD, PhD, and Josephine and Richard Weil. […]